Therapeutic activity of 4-allyloxy-3-chlorophenylacetic acid.
D000700:Analgesics / Q000008:administration & dosage*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D002986:Clinical Trials as Topic; D003061:Codeine / Q000008:administration & dosage*; D006801:Humans; D007213:Indomethacin / Q000008:administration & dosage; D009020:Morphine / Q000008:administration & dosage; D009369:Neoplasms / Q000188:drug therapy*; D010003:Osteoarthritis / Q000188:drug therapy; D010423:Pentazocine / Q000008:administration & dosage; D010648:Phenylacetates / Q000008:administration & dosage* / Q000009:adverse effects; D010653:Phenylbutazone / Q000008:administration & dosage; D010919:Placebos; D012216:Rheumatic Diseases / Q000188:drug therapy*; D012213:Rheumatic Fever / Q000188:drug therapy
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D010648:Phenylacetates; D010919:Placebos; D009020:Morphine; D010653:Phenylbutazone; D010423:Pentazocine; D003061:Codeine; D007213:Indomethacin